Raymond James & Associates’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $515K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $242K | Sell |
|
|||||
|
2019
Q3 | $347K | Sell |
|
|||||
|
2019
Q2 | $402K | Sell |
|
|||||
|
2019
Q1 | $375K | Sell |
|
|||||
|
2018
Q4 | $671K | Buy |
|
|||||
|
2018
Q3 | $673K | Buy |
|
|||||
|
2018
Q2 | $698K | Sell |
|
|||||
|
2018
Q1 | $840K | Sell |
|
|||||
|
2017
Q4 | $1.38M | Sell |
|
|||||
|
2017
Q3 | $1.21M | Buy |
|
|||||
|
2017
Q2 | $235K | Sell |
|
|||||
|
2017
Q1 | $266K | Buy |
|
|||||
|
2016
Q4 | $320K | Buy |
|
|||||
|
2016
Q3 | $331K | Buy |
|